NEWS & RESOURCES

Bioscience

Positive Session for Bioscience Sector

The 2026 General Assembly session was one of the least contentious in recent memory for the biopharma sector. Bills calling for innovation-sapping price controls and unworkable programs…

News

Boehringer Partners on Connecticut Science Center STEM Lab

The Connecticut Science Center is home to exhibits, programs, and…

News

Costly Public Option Precursor Advances

The Connecticut General Assembly is exploring ways to address rising…

Content Type:

Bioscience

04.05.2018

Bioscience Company Moves New York City Jobs to Connecticut

The state’s bioscience sector got a big boost this...

Bioscience

03.23.2018

Bioscience, Fiscal Reform Measures Will Drive Greater Investment

It’s not difficult to see why Connecticut’s bioscience sector...

Bioscience

03.08.2018

Healthcare Cabinet Issues Prescription Drug Cost Recommendations

Connecticut’s Healthcare Cabinet has issued a series of policy...

Bioscience

12.19.2017

Connecticut Maintains High Technology, Innovation Ranking

Connecticut continues to rank among the top 10 states...

Bioscience

09.27.2017

Lessons We Can Learn from Alexion’s Departure

There are few teachable moments as rich as Alexion’s...

Bioscience

07.11.2017

Governor Signs Several Pro-Business Bills

Governor Dannel Malloy recently signed several bills designed to...

Bioscience

06.09.2017

Biopharma Faces Complex Issues in 2017 Session

Biopharma and the life sciences fared relatively well in...

Bioscience

05.26.2017

Positive Steps for Economic Development

Amid the concerns and difficult choices surrounding the state’s...

Bioscience

05.04.2017

Amid Budget Woes, Life Sciences Legislation Shines

Lost in the ongoing drama over Connecticut’s ailing economy—new...

Stay Connected with CBIA News Digests

The latest news and information delivered directly to your inbox.

Economy

HR & Safety

Issues & Policies

Manufacturing

Member News

Media Center

Small Business

Workforce

Take Action

Bioscience

Positive Session for Bioscience Sector

Boehringer Partners on Connecticut Science Center STEM Lab

Costly Public Option Precursor Advances

Bioscience Company Moves New York City Jobs to Connecticut

Bioscience, Fiscal Reform Measures Will Drive Greater Investment

Healthcare Cabinet Issues Prescription Drug Cost Recommendations

Connecticut Maintains High Technology, Innovation Ranking

Lessons We Can Learn from Alexion’s Departure

Governor Signs Several Pro-Business Bills

Biopharma Faces Complex Issues in 2017 Session

Positive Steps for Economic Development

Amid Budget Woes, Life Sciences Legislation Shines

Stay Connected with CBIA News Digests

2025 Manufacturing Tour

Company Name & Address

Company Contact Info